Saudi FM and new UK counterpart discuss regional situation in phone call    Saudi Arabia, Syria sign 11 qualitative deals at Damascus Fair    Saudi skies witness rare Blood Moon total lunar eclipse    European leaders to visit US to discuss war in Ukraine, Trump says    South Korean worker describes panic and confusion during Hyundai ICE raid    The key to happiness    66% of 12.9 million extremist messages, monitored by Etidal in 90 days, incite violence    KSrelief launches relief and humanitarian projects during visit of Al-Rabeeah to Syria    OPEC+ to increase further oil output in October    Japan's Prime Minister resigns after election defeat pressures    Saudi Justice Ministry to host 2nd International Conference on Judicial Training in Riyadh    Over 47,000 transport violations detected during 340,000 TGA inspections in August    Amended Contractors Classification Law regulations set criteria for dividing major projects    Gamers frustrated as Hollow Knight: Silksong crashes stores on launch    'My mother was my shelter and storm': Arundhati Roy on her fierce new memoir    Mike Tyson and Floyd Mayweather Jr. set to meet in exhibition boxing match in 2026    HONOR to participate in Global Symposium for Regulators 2025 in Saudi Arabia    NVIDIA GeForce RTX 50 Series laptops redefine learning, creating and gaming    Al Hilal sign Turkish defender Yusuf Akcicek on €22m deal until 2029    Al Qadsiah sign German midfielder Julian Weigl to strengthen defensive midfield    Al Ahli secure Flamengo starlet Matheus Gonçalves in long-term deal through 2027    Sholay: Bollywood epic roars back to big screen after 50 years with new ending    Ministry launches online booking for slaughterhouses on eve of Eid Al-Adha    Shah Rukh Khan makes Met Gala debut in Sabyasachi    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



RDIF, Pharco agree to supply 25 million doses of Sputnik V vaccine to Egypt
Published in The Saudi Gazette on 30 - 09 - 2020

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and Pharco, one of the leading pharmaceutical groups in Egypt (acting through its key operational subsidiary – Biogeneric Pharma) have agreed to secure the supply of 25 million doses of the Sputnik V vaccine to Egypt.
The vaccine, which is based on a well-studied human adenoviral vectors platform with proven safety and efficacy, will support the efforts of the Ministry of Health of Egypt to secure a vaccine against COVID-19.
The agreement will enable 25% of Egypt's population to have access to the Sputnik V vaccine. In the future, it is planned to distribute it to neighboring countries.
Egypt will secure a diversified vaccine portfolio, which includes a vaccine based on the human adenoviral vectors platform. This platform has proven safe over decades including through 75 international scientific publications and in more than 250 clinical trials.
Clinical trials of the Russian vaccine have shown no serious adverse events, with Sputnik V generating a stable humoral and cellular immune response in 100% of participants. In contrast, vaccines based on novel platforms have yet to prove their safety and currently have no data on carcinogenicity or effects on fertility.
On Aug. 11, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform.
Detailed information on the Sputnik V vaccine, the technological platform of human adenoviral vectors, and other details are available at sputnikvaccine.com
On Sept. 4, a research paper on the results of Phase I and Phase II clinical trials of the Sputnik V vaccine was published in The Lancet, one of the leading international medical journals.
Post-registration clinical trials of the Sputnik V vaccine involving 40,000 volunteers are currently ongoing. More than 60,000 volunteers have applied to take part in post-registration trials. The first results of these trials are expected to be published in October-November 2020.
More than 50 countries in the Middle East, Asia, Latin America, Europe and CIS have applied for Sputnik V. RDIF has already announced supply agreements with Mexico for 32 million doses, with Brazil for up to 50 million doses, India — 100 million doses, Uzbekistan — for up to 35 million doses and Nepal for 25 million doses.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said: "The agreement between RDIF and Pharco will help Egypt obtain an efficient and safe vaccine, Sputnik V, for almost 25% of its population. The adenoviral vectors platform has a longer safety track record compared to novel technologies such as monkey adenoviral vectors or mRNA used by other vaccine manufacturers.
"So the people of Egypt will get a proven vaccine created on a platform with no negative long-term effects, including carcinogenicity or risks for fertility in the future. We expect more countries to include Sputnik V in their vaccine portfolios in the coming weeks."
Dr. Sherine Abbas Helmy, founder and president of Pharco, said: "We greatly appreciate this agreement to secure supplies of the Russian Sputnik V vaccine with proven safety to Egypt. Besides vaccine supply, we are considering numerous further cooperation opportunities jointly with RDIF, including the localization of production in Egypt at the facilities of Biogeneric Pharma within the next few months for the benefit of both countries."
Feliks Ershov, virologist, and academician of the Russian Academy of Sciences, noted: "This pandemic will not be completely eradicated without a vaccine. The vaccine created by the Gamaleya Center is not one-piece, like the vaccines of the past, (containing a live or killed virus). It is made using modern biotechnology and a proven platform, in contrast to products by a number of companies based on mRNA or the monkey adenovirus, which have not been tested before.
"The safety of the Sputnik V vaccine is ensured by using a simple flu virus that is harmless to humans and does not contain the coronavirus itself — only a part of its genetic code, which excludes the possibility of infection. But the antibodies response necessary to protect the body is ensured, which was confirmed by the results of trials.
"The use of two consecutive shots with different mechanisms of delivery of the virus code into the body guarantees immunization and represents a unique advantage of the Russian vaccine." — PRNewswire


Clic here to read the story from its source.